A Brief Introduction to the Opioid Epidemic Christopher M. Jones, - - PowerPoint PPT Presentation

a brief introduction to the opioid epidemic
SMART_READER_LITE
LIVE PREVIEW

A Brief Introduction to the Opioid Epidemic Christopher M. Jones, - - PowerPoint PPT Presentation

A Brief Introduction to the Opioid Epidemic Christopher M. Jones, PharmD, MPH CDR, US Public Health Service Director, Division of Science Policy Office of the Assistant Secretary for Planning and Evaluation Overview Epidemiology crash


slide-1
SLIDE 1

A Brief Introduction to the Opioid Epidemic

Christopher M. Jones, PharmD, MPH

CDR, US Public Health Service Director, Division of Science Policy Office of the Assistant Secretary for Planning and Evaluation

slide-2
SLIDE 2

Overview

  • Epidemiology crash course
  • Policy and information sharing
slide-3
SLIDE 3

Source: CDC/NCHS, National Vital Statistics System, Mortality File.

5 10 15 20 25 1980 1985 1990 1995 2000 2005 2010 2014

Deaths per 100,000 population

MV Traffic Drug Poisoning

Age-adjusted death rates for Motor Vehicle Traffic and Drug Poisoning, United States,1980-2014

slide-4
SLIDE 4

2002

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-5
SLIDE 5

2003

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-6
SLIDE 6

2004

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-7
SLIDE 7

2005

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-8
SLIDE 8

2006

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-9
SLIDE 9

2007

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-10
SLIDE 10

2008

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-11
SLIDE 11

2009

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-12
SLIDE 12

2010

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-13
SLIDE 13

2011

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-14
SLIDE 14

2012

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-15
SLIDE 15

2013

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

slide-16
SLIDE 16

2002 2013

Source: CDC, NVSS, Slide courtesy of M. Warner, CDC/NCHS

2013 2002

slide-17
SLIDE 17

Rx opioids mostly commonly abused prescription drug, US, 2014

Source: SAMHSA National Survey on Drug Use and Health, 2014

500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 Rx Opioids Tranquilizers Stimulants Sedatives

Number of people reporting behavior (in thousands)

Initiation Dependence or Abuse Past Month Nonmedical Use

slide-18
SLIDE 18

Past year opioid use disorders, US, 2003-2014

18

500,000 1,000,000 1,500,000 2,000,000 2,500,000 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Number of Individuals

Any Opioid Use Disorder Prescription Opioid Use Disorder Heroin Use Disorder

Source: SAMHSA, NSDUH 2003-2014 PUF

slide-19
SLIDE 19

Opioid-related overdose deaths, US, 1999-2014

1 2 3 4 5 6 7 8 9 10 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Age Adjusted-Rate per 100,000 population All Opioids Heroin Natural/Semi-Sythetic Opioids Methadone Synthetic Opioids

slide-20
SLIDE 20

Increases in Rx opioid prescribing coincide with increases in Rx opioid overdose deaths

1 2 3 4 5 6 7 8 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Rate

Source: CDC/NVSS and DEA ARCOS. KG of morphine milligram equivalent per 10,000 population Opioid overdose deaths per 100,000 population

slide-21
SLIDE 21

Primary care physician’s views on Rx opioids

10 20 30 40 50 60 No problem at all Small problem Moderate problem Big problem Percent

Magnitude of Rx abuse in community

10 20 30 40 50 60 Strongly disagree Somewhat disagree Somewhat agree Strongly agree Percent

Opioids overused for pain

10 20 30 40 50 60 Not at all Slightly Moderately Very Percent

Confidence in clinical skills related to opioid prescribing

10 20 30 40 50 60 Not at all Slightly Moderately Very Percent

Comfort in prescribing opioids for chronic noncancer pain

Source: Hwang et al. Prescription drug abuse: a national survey of primary care physicians. JAMA 2015

slide-22
SLIDE 22

Increase in opioid prescribing dose for same conditions over time

Source: Wunsch et al. JAMA 2016

slide-23
SLIDE 23

Changing demographics of heroin use

Source: Jones CM et al. MMWR 2016; Cicero et al JAMA Psychiatry 2014.

slide-24
SLIDE 24

Multiple facets of the opioid epidemic

slide-25
SLIDE 25

 Demographics

▪ Men ▪ 35-54 year olds (deaths) ▪ 18-35 (abuse) ▪ Whites ▪ American Indians/Alaska Natives

 Socioeconomics and

Geography

▪ Medicaid, uninsured ▪ Rural

 Clinical Characteristics

▪ Chronic pain ▪ Substance abuse ▪ Mental health ▪ Nonmedical use ▪ Multiple prescriptions ▪ Multiple prescribers ▪ High daily dosage ▪ Combination of opioids and benzodiazepines

Risk factors for Rx opioid abuse and overdose

slide-26
SLIDE 26

Use data to identify patients in need of treatment and improve continuity of information across information systems

  • PDMPs

– Key piece of information in the clinical work flow – Starting point for a conversation with patients

  • EHRs

– Like PDMPs, could provide full visibility on prior drug and treatment exposure, clinical conditions, risk factors – Clinical decision support can facilitate screening, assessment, intervention, and monitoring – Incorporate guidelines on appropriate prescribing for both acute and chronic pain conditions

  • Insurer/PBM data/Claims data

– Examine utilization patterns to identify patients at risk or abusing substances – Academic detailing, alerts to providers, alters to patients, connection with employee assistance programs, etc.

  • Connection with other information systems such as human and social services,

inpatient systems, etc., is needed

slide-27
SLIDE 27

HHS Opioid Initiative

  • Launched by Secretary

Burwell in March 2015

  • Three focus areas

– Improve opioid prescribing – Increase use of naloxone to reverse opioid overdose – Expand use of Medication- Assisted Treatment (MAT) for

  • pioid use disorders
slide-28
SLIDE 28

THANK YOU QUESTIONS?

CHRISTOPHER.JONES@HHS.GOV